(Q40623296)

22 September 2017

title

Cutaneous presentation of posttransplant lymphoproliferative disorder (English)

1 reference

22 September 2017

Schumann KW

1

1 reference

22 September 2017

Oriba HA

2

1 reference

22 September 2017

Bergfeld WF

3

1 reference

22 September 2017

Hsi ED

4

1 reference

22 September 2017

Hollandsworth K

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

Journal of the American Academy of Dermatology

22 September 2017

published in

1 reference

22 September 2017

volume

42

1 reference

22 September 2017

issue

5 Pt 2

1 reference

22 September 2017

page(s)

923-926

1 reference

Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

B-cell lymphoproliferative disorders in solid-organ transplant patients: Detection of Epstein-Barr virus by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Posttransplantation lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Clinical characteristics of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Posttransplant lymphoproliferative disorder presenting as an isolated skin lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Cancers following cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Treatment of organ transplant-related lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990273-1

7 January 2021

10.1016/S0190-9622(00)90273-1

Identifiers

DOI

1 reference

22 September 2017

1 reference